Eagle Pharmaceuticals, Inc. Treasury Stock, Value
Eagle Pharmaceuticals, Inc. had Treasury Stock, Value of $243.12 million as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Treasury Stock, Value
us-gaap:TreasuryStockValue · last filed 2023-03-23
- 2022-12-31: Treasury Stock, Value $243.12M.
- 2022-09-30: Treasury Stock, Value $243.12M.
- 2022-06-30: Treasury Stock, Value $233.16M.
- 2022-03-31: Treasury Stock, Value $233.16M.
| Period end | Treasury Stock, Value |
|---|---|
| 2022-12-31 | $243.12M 10-K · filed 2023-03-23 |
| 2022-09-30 | $243.12M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $233.16M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $233.16M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $225.11M 10-K · filed 2023-03-23 |
| 2021-09-30 | $216.47M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $208.19M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $205.33M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $203.90M 10-K · filed 2022-03-08 |
| 2020-09-30 | $199.86M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $176.86M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $172.86M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $171.86M 10-K · filed 2021-03-05 |
| 2019-09-30 | $168.90M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $168.90M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $153.90M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $153.90M 10-K · filed 2020-03-02 |
| 2018-09-30 | $103.42M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $91.31M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $87.80M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $80.80M 10-K · filed 2019-02-28 |
| 2017-09-30 | $75.79M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $62.31M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $50.66M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $37.00M 10-K · filed 2018-02-26 |
| 2016-09-30 | $18.00M 10-Q · filed 2016-11-09 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |